Main content

    Cardiology Clinical Trials

    Heart Failure, LVAD & Heart Transplant ProgramOpens new window

    Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at

    Active Studies

    Title: Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ IDE Clinical Study Protocol
    Description: The objective of the study is to evaluate the safety and effectiveness of the HM3 LVAS by demonstrating non-inferiority to the HMII LVAS (HMII) when used for the treatment of advanced, refractory, left ventricular heart failure.
    Investigator: Brett Sheridan, MD
    Eligibility: Subjects, 18 y/o and older, with NYHA Class III with dyspnea upon mild physical activity, or NYHA Class IV; LVEF ≤ 25%; and inotrope dependent OR CI < 2.2 L/min/m2, while not on inotropes
    Status: Active and open to enrollment
    Contact: Douglas Raggett, RN, 415-600-3777, Email: about Study Momentum 3

    • updated July 2016